Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Acetaminophen Dose Warning Issued by FDA Over Liquid Infant Drugs December 23, 2011 Staff Writers Add Your Comments New liquid acetaminophen products for infants have federal health officials concerned about accidental Tylenol overdoses and dosing confusion by parents. The FDA issued a consumer update on December 22, warning parents that a number of new liquid acetaminophen products for infants have different potency than older liquid acetaminophen medications. The agency fears that parents and caregivers of infants and children may accidentally give a child too much of the drug because they are used to the dosing sizes of older brands of liquid acetaminophen drops. They may also give too little of the drug, making it ineffective. Tylenol Autism Lawsuit Does your child have Autism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tylenol Autism Lawsuit Does your child have Autism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION Acetaminophenis a pain killer and anti-inflammatory medication found in a number of over-the-counter and prescription drugs. It is also widely marketed for use among infants and children for the treatment of fever, aches and pain. Medication errors with acetaminophen led to 14 deaths and 74 injuries from 2000 to 2010 in children under the age of 13, according to the FDA. In response to concerns raised by the FDA over the high potency of many infant liquid acetaminophen products, a number of drug makers have reformulated their medications to be more diluted. They were previously sold in 80 mg/0.8 mL and 80 mg/mL concentrations. However, a new version of the medications has been diluted to 160 mg/5 mL. The previous versions came with droppers for dosing, while many new one comes with an oral syringe. The change was voluntary and not all drug manufacturers have adopted it. This means that a number of concentrations are now on store shelves, which could confuse parents. The FDA is urging parents to carefully read the dosing instructions and medication guides of this and all other drugs, and to use the dosing device included in the packaging. Even in cases where a product changed, the packaging often changed very little, which could lead to confusion if the person bought older versions of the drug and then bought the new version not realizing there was a difference. One example of this the FDA held up was Little Fevers by Little Remedies. Both boxes say “New!” on the front and are very similar in design, but are of different concentrations. The FDA did not provide a full list of the products that changed their formulations. Instead, telling parents to read every medication guide and dosing instructions every time a purchase is made. There is no recommended dosing for children under the age of two, so parents should also consult their physician any time they intend to give acetaminophen to infants, the agency warned. According to the FDA, acetaminophen overdose has been a leading cause of liver failure in the United States, resulting in more than 50,000 emergency room visits, 25,000 hospitalizations and over 450 deaths annually. Due to the risks associated with receiving too much acetaminophen, an FDA advisory panel was convened in May to make recommendations about new warnings or other regulatory actions. The panel recommended that dosing instructions be based on a child’s weight instead of their age. Stronger warnings about the potential risk of liver failure from acetaminophen have also been added to all products over the past year, including clearer indications about what products contain acetaminophen as the active ingredient to avoid the risk of overdose. Tags: Acetaminophen, Children, Liver Damage, Liver Failure, Liver Toxicity, Medication Error, Overdose Image Credit: | More Tylenol Lawsuit Stories Study Raises Doubts About Link Between Tylenol and Autism in Children November 25, 2025 Texas Tylenol Lawsuit Accuses J&J of Failing To Warn of Autism Risks October 29, 2025 Tylenol Autism Warnings Challenged by J&J Spinoff Kenvue October 23, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: today) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025) Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025) Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: today) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)